FDA’s Shuren: Staff Overburdened, Review Times Seeing Negative Effects

Shuren_Jeff_1200
CDRH director Jeff Shuren is worried his staff are burning out and as a result reviews are taking longer • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation